Ajanta Pharma has established a solid footprint in over 30 emerging markets across Africa, South-East Asia, Central Asia and the Middle East.
In recent years our branded generics presence has grown deeper as we introduced more products, expanded field teams and strengthened leadership in several therapeutic areas.
We have built a solid on-ground presence through our own dedicated sales teams which ensure effective brand promotion. With more than 220 brands, many of our products command significant market shares and enjoy leadership positions in their categories.
At Ajanta, our key strengths are our ability to identify gaps in marketplace, obtaining the regulatory approvals for new products and launching differentiated products that grow into high performing brands. Our sales and marketing capabilities are 2nd to none having laser focused determination on execution.
In Emerging (ROW) Markets, we have presence in wide range of therapeutic segments like, Cardiology, Anti-Diabetes, Ophthalmology, Antibiotic, Anti-Malarial, Pain, Respiratory, Gynaecology, Paediatric and General Health products.
We have robust product pipeline under regulatory approvals in these markets which will further consolidate our leadership positions in sub-therapeutic and therapeutic segments.